Detalhe da pesquisa
1.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med
; 387(23): 2113-2125, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477031
2.
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Int J Cancer
; 154(10): 1760-1771, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296842
3.
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Cancer
; 130(9): 1673-1683, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198485
4.
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.
Rheumatology (Oxford)
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335930
5.
Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer.
Histopathology
; 84(6): 935-946, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38192084
6.
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.
Int J Cancer
; 153(2): 389-398, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843260
7.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
; 152(12): 2493-2502, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843274
8.
Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery: A 5-Year Follow-up of the RAPIDO Trial.
Ann Surg
; 278(4): e766-e772, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661037
9.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203067
10.
Relevance of shrinkage versus fragmented response patterns in rectal cancer.
Histopathology
; 83(6): 870-879, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609761
11.
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
BMC Cancer
; 23(1): 166, 2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805683
12.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605003
13.
Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.
Int J Cancer
; 150(2): 317-326, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520567
14.
Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.
BMC Cancer
; 22(1): 247, 2022 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247992
15.
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
Ann Intern Med
; 174(5): 641-648, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587686
16.
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 29-42, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301740
17.
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy.
Cancer Metastasis Rev
; 39(3): 999-1013, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367253
18.
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.
Br J Cancer
; 124(7): 1222-1230, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495600
19.
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
Cancer Immunol Immunother
; 70(11): 3123-3135, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33774697
20.
Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible.
Ann Surg Oncol
; 28(9): 5194-5204, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023946